Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2026-06-21 @ 11:27 AM
Study NCT ID:
NCT04985851
Status:
UNKNOWN
Last Update Posted:
2023-12-01
First Post:
2021-06-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
Sponsor:
Shanghai Chest Hospital
Organization: